Technology | Breast Imaging | January 25, 2017

HealthDecision LLC Launches Personalized Breast Cancer Screening Software Tool

Software embedded within electronic health records looks at patient’s healthcare data and history to calculate individual risk for developing breast cancer in the next decade

HealthDecision, Breast Cancer Screening tool, personalized risk, UW Health, launch

January 25, 2017 — HealthDecision LLC recently announced the launch of the Breast Cancer Screening tool. This tool provides patients a personalized risk analysis for developing breast cancer in the next 10 years and the benefits or harms associated with mammogram screening.

The tool was tested and currently is used within University of Wisconsin (UW) Health, a healthcare system in the upper Midwest serving 600,000 patients each year with 1,400 physicians and 16,500 staff at six hospitals and 80 outpatient sites.

The Breast Cancer Screening tool is the result of a 2013 WI Partnership Program grant received by the UW Madison Department of Radiology and a joint effort with HealthDecision LLC to create a shared decision-making (SDM) tool that could be used at a routine appointment within a doctor's office. The project grew out of the controversy and confusion about breast cancer screening, and its multidisciplinary team included members from surgery, engineering, psychology, communications, primary care, vascular surgery research and decision making.

HealthDecision is unique in that it is embedded within the electronic health record (EHR) system and considers the patient's healthcare data and history to calculate personalized risk. Risks associated with mammogram screening include over-detection and the subsequent effects of anxiety; possible overtreatment with surgery, radiotherapy and sometimes chemotherapy; cost; and additional impacts on quality of life.

"Healthcare guidelines can be confusing to patients as well as doctors, especially when there is conflicting information in the public domain," said Sarina Schrager, M.D., UW Health and professor in the University of Wisconsin Department of Family Medicine and Community Health. Along with Beth Burnside, M.D., UW Health, who was the principle investigator on the grant, Schrager was heavily involved in the development of the tool, educating other primary care clinicians and driving the implementation strategy within UW Health primary care. "HealthDecision aids my conversation with the patient to better educate and explain the harms and benefits of a mammogram and its possible outcomes. The visualized risk analysis has been key for patients to better understand their personalized risk and increases their confidence to make better informed healthcare decisions for themselves."

The Breast Cancer Screening tool joins a suite of three other HealthDecision shared decision-making tools that provide a patient's personalized risk for the various healthcare options available:

  • The Atrial Fibrillation tool demonstrates a patient's risk of stroke or bleeding from anticoagulant medications;
  • The Cardiovascular Risk tool evaluates a patient's cholesterol and their risk of various statin medications and smoking cessation; and
  • The Lung Cancer Screening tool considers the risk for chest computed tomography (CT) scans for patients who smoke or have smoked.

For more information: www.healthdecision.org

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init